or Try an Advanced Search...

    Technical Analysis for SWTX - SpringWorks Therapeutics, Inc.

    Grade Last Price % Change Price Change
    D 37.67 0.37% 0.14
    SWTX closed up 0.37 percent on Friday, June 28, 2024, on 1.26 times normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Down Up
    Historical SWTX trend table...
    Date Alert Name Type % Chg
    Slingshot Bearish Bearish Swing Setup 0.00%
    200 DMA Support Bullish 0.00%
    Doji - Bearish? Reversal 0.00%
    Bullish Engulfing Bullish 0.37%
    Crossed Above 200 DMA Bullish 0.37%
    MACD Bullish Signal Line Cross Bullish 0.37%
    Outside Day Range Expansion 0.37%
    Oversold Stochastic Weakness 0.37%
    Oversold Stochastic Weakness 4.00%
    Inside Day Range Contraction 3.49%
    Older End-of-Day Signals for SWTX ...

       Recent Intraday Alerts

    Alert Time
    200 DMA Support 2 days ago
    10 DMA Support 2 days ago
    60 Minute Opening Range Breakdown 2 days ago
    Down 2 % 2 days ago
    Fell Below 10 DMA 2 days ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    SWTX Chart by TradingView
    Basic chart:

    Profile

    Springworks Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It identifies pathways for drug development for patients with severe rare diseases and cancer. The firm's products include Nirogacestat, Mirdametinib and BGB-3245. The company was founded in August 2017 and is headquartered in Stamford, CT.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmacy Rare Diseases Drug Development

    Is SWTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 8 GSK, SpringWorks end collaboration agreement
    Jun 6 Insider Sale: Director Julie Hambleton Sells Shares of SpringWorks Therapeutics Inc (SWTX)
    Jun 6 Insider Sale: COO Badreddin Edris Sells 20,000 Shares of SpringWorks Therapeutics Inc (SWTX)
    Jun 6 Insider Sale: CEO Saqib Islam Sells 49,000 Shares of SpringWorks Therapeutics Inc (SWTX)
    Jun 5 SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
    May 23 SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
    May 8 SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference
    May 5 SpringWorks Therapeutics, Inc. (SWTX) Q1 2024 Earnings Call Transcript
    May 5 SpringWorks Therapeutics, Inc. 2024 Q1 - Results - Earnings Call Presentation
    May 3 Here's Why We're Not Too Worried About SpringWorks Therapeutics' (NASDAQ:SWTX) Cash Burn Situation
    See more SWTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 53.92
    52 Week Low 18.0
    Average Volume 852,845
    200-Day Moving Average 37.19
    50-Day Moving Average 41.48
    20-Day Moving Average 38.24
    10-Day Moving Average 36.76
    Average True Range 1.78
    RSI (14) 42.53
    ADX 26.42
    +DI 15.04
    -DI 21.22
    Chandelier Exit (Long, 3 ATRs) 38.41
    Chandelier Exit (Short, 3 ATRs) 40.50
    Upper Bollinger Bands 41.61
    Lower Bollinger Band 34.86
    Percent B (%b) 0.42
    BandWidth 17.64
    MACD Line -1.49
    MACD Signal Line -1.60
    MACD Histogram 0.115
    Fundamentals Value
    Market Cap 2.71 Billion
    Num Shares 72.1 Million
    EPS -4.87
    Price-to-Earnings (P/E) Ratio -7.74
    Price-to-Sales 74.50
    Price-to-Book 8.55
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 40.28
    Resistance 3 (R3) 40.17 39.20 39.85
    Resistance 2 (R2) 39.20 38.53 39.25 39.70
    Resistance 1 (R1) 38.43 38.12 37.95 38.54 39.55
    Pivot Point 37.46 37.46 37.21 37.51 37.46
    Support 1 (S1) 36.69 36.79 36.21 36.80 35.79
    Support 2 (S2) 35.72 36.38 35.77 35.64
    Support 3 (S3) 34.95 35.72 35.50
    Support 4 (S4) 35.06